|
1
|
Chargari C, Moncharmont C, Lévy A, et al:
Cancer stem cells, cornerstone of radioresistance and perspectives
for radiosensitization: glioblastoma as an example. Bull Cancer.
99:1153–1160. 2012.(In French).
|
|
2
|
Malik B and Nie D: Cancer stem cells and
resistance to chemo and radio therapy. Front Biosci. 4:2142–2149.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Krause M, Yaromina A, Eicheler W, Koch U
and Baumann M: Cancer stem cells: targets and potential biomarkers
for radiotherapy. Clin Cancer Res. 17:7224–7229. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park IK, Qian D, Kiel M, et al: Bmi-1 is
required for maintenance of adult self-renewing haematopoietic stem
cells. Nature. 423:302–305. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grinstein E and Mahotka C: Stem cell
divisions controlled by the proto-oncogene BMI-1. J Stem Cells.
4:141–146. 2009.PubMed/NCBI
|
|
6
|
Lukacs RU, Memarzadeh S, Wu H and Witte
ON: Bmi-1 is a crucial regulator of prostate stem cell self-renewal
and malignant transformation. Cell Stem Cell. 7:682–693. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yamazaki H, Mori T, Yazawa M, et al: Stem
cell self-renewal factors Bmi1 and HMGA2 in head and neck squamous
cell carcinoma: clues for diagnosis. Lab Invest. 93:1331–1338.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sinha N, Mukhopadhyay S, Das DN, Panda PK
and Bhutia SK: Relevance of cancer initiating/stem cells in
carcinogenesis and therapy resistance in oral cancer. Oral Oncol.
49:854–862. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shien K, Toyooka S, Ichimura K, et al:
Prognostic impact of cancer stem cell-related markers in non-small
cell lung cancer patients treated with induction chemoradiotherapy.
Lung Cancer. 77:162–167. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu ZG, Liu L, Xu LH, et al: Bmi-1 induces
radioresistance in MCF-7 mammary carcinoma cells. Oncol Rep.
27:1116–1122. 2012.PubMed/NCBI
|
|
11
|
Moscatelli D and Lynette Wilson E: Bmi-1,
stem cells and prostate carcinogenesis. Asian J Androl. 13:353–354.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu X, Li H, Jiang X, Guo L, Jiang W and Lu
SH: miR-203 inhibits the proliferation and self-renewal of
esophageal cancer stem-like cells by suppressing stem renewal
factor Bmi-1. Stem Cells Dev. 23:576–585. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang HB, Liu GH, Zhang H, et al: Sp1 and
c-Myc regulate transcription of BMI1 in nasopharyngeal
carcinoma. FEBS J. 280:2929–2944. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang G, Liu L, Sharma S, et al: Bmi-1
confers adaptive radioresistance to KYSE-150R esophageal carcinoma
cells. Biochem Biophys Res Commun. 425:309–314. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Alajez NM, Shi W, Hui AB, et al: Targeted
depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis
in response to radiation therapy. Cell Death Differ. 16:1469–1479.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Su J, Xu XH, Huang Q, et al:
Identification of cancer stem-like CD44+ cells in human
nasopharyngeal carcinoma cell line. Arch Med Res. 42:15–21. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen YC, Chang CJ, Hsu HS, et al:
Inhibition of tumorigenicity and enhancement of
radiochemosensitivity in head and neck squamous cell cancer-derived
ALDH1-positive cells by knockdown of Bmi-1. Oral Oncol. 46:158–165.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Häyry V, Mäkinen LK, Atula T, et al: Bmi-1
expression predicts prognosis in squamous cell carcinoma of the
tongue. Br J Cancer. 102:892–897. 2010.PubMed/NCBI
|
|
19
|
Häyry V, Tynninen O, Haapasalo HK, et al:
Stem cell protein BMI-1 is an independent marker for poor prognosis
in oligodendroglial tumours. Neuropathol Appl Neurobiol.
34:555–563. 2008.PubMed/NCBI
|
|
20
|
Smith KS, Chanda SK, Lingbeek M, et al:
Bmi-1 regulation of INK4A-ARF is a downstream requirement for
transformation of hematopoietic progenitors by E2a-Pbx1. Mol Cell.
12:393–400. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Calao M, Sekyere EO, Cui HJ, et al: Direct
effects of Bmi1 on p53 protein stability inactivates oncoprotein
stress responses in embryonal cancer precursor cells at tumor
initiation. Oncogene. 32:3616–3626. 2013. View Article : Google Scholar
|
|
22
|
Fujii H, Honoki K, Tsujiuchi T, et al:
Reduced expression of INK4a/ARF genes in stem-like sphere cells
from rat sarcomas. Biochem Biophys Res Commun. 362:773–778. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim K, Kim DH, Chae SW, et al: Expression
of cell cycle-related proteins, p16, p53 and p63 as important
prognostic markers in gallbladder adenocarcinoma. Pathol Oncol Res.
20:409–415. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Scully R and Xie A: Double strand break
repair functions of histone H2AX. Mutat Res. 750:5–14. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gieni RS, Ismail IH, Campbell S and
Hendzel MJ: Polycomb group proteins in the DNA damage response: a
link between radiation resistance and ‘stemness’. Cell Cycle.
10:883–894. 2011.PubMed/NCBI
|
|
26
|
Facchino S, Abdouh M, Chatoo W and Bernier
G: BMI1 confers radioresistance to normal and cancerous neural stem
cells through recruitment of the DNA damage response machinery. J
Neurosci. 30:10096–10111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Iwama A, Oguro H, Negishi M, et al:
Enhanced self-renewal of hematopoietic stem cells mediated by the
polycomb gene product Bmi-1. Immunity. 21:843–851. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huber GF, Albinger-Hegyi A, Soltermann A,
et al: Expression patterns of Bmi-1 and p16 significantly correlate
with overall, disease-specific, and recurrence-free survival in
oropharyngeal squamous cell carcinoma. Cancer. 117:4659–4670. 2011.
View Article : Google Scholar
|
|
29
|
Santivasi WL and Xia F: Ionizing
radiation-induced DNA damage, response, and repair. Antioxid Redox
Signal. Feb 3–2014.(Epub ahead of print).
|
|
30
|
Mladenov E, Magin S, Soni A and Iliakis G:
DNA double-strand break repair as determinant of cellular
radiosensitivity to killing and target in radiation therapy. Front
Oncol. 3:1132013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gilbert DC, Williams A, Allan K, et al:
p16INK4A, p53, EGFR expression and KRAS mutation status
in squamous cell cancers of the anus: correlation with outcomes
following chemo-radiotherapy. Radiother Oncol. 109:146–151.
2013.
|
|
32
|
Dong Q, Oh JE, Chen W, et al:
Radioprotective effects of Bmi-1 involve epigenetic silencing of
oxidase genes and enhanced DNA repair in normal human
keratinocytes. J Invest Dermatol. 131:1216–1225. 2011. View Article : Google Scholar : PubMed/NCBI
|
